These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8022862)
21. Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679. deSolms SJ; Giuliani EA; Guare JP; Vacca JP; Sanders WM; Graham SL; Wiggins JM; Darke PL; Sigal IS; Zugay JA J Med Chem; 1991 Sep; 34(9):2852-7. PubMed ID: 1910089 [TBL] [Abstract][Full Text] [Related]
22. Rational design of peptide-based HIV proteinase inhibitors. Roberts NA; Martin JA; Kinchington D; Broadhurst AV; Craig JC; Duncan IB; Galpin SA; Handa BK; Kay J; Kröhn A Science; 1990 Apr; 248(4953):358-61. PubMed ID: 2183354 [TBL] [Abstract][Full Text] [Related]
23. 6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity. Holý A; Votruba I; Masojídková M; Andrei G; Snoeck R; Naesens L; De Clercq E; Balzarini J J Med Chem; 2002 Apr; 45(9):1918-29. PubMed ID: 11960502 [TBL] [Abstract][Full Text] [Related]
24. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1. An T; Ouyang W; Pan W; Guo D; Li J; Li L; Chen G; Yang J; Wu S; Tien P Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469 [TBL] [Abstract][Full Text] [Related]
26. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-H5N1 activity of chiral gossypol derivatives and its analogs implicated by a viral entry blocking mechanism. Yang J; Chen G; Li LL; Pan W; Zhang F; Yang J; Wu S; Tien P Bioorg Med Chem Lett; 2013 May; 23(9):2619-23. PubMed ID: 23538114 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and anti-HSV activity of new N1-acyclic C4 and C6-disubstituted pyrazolo[3,4-d]pyrimidine nucleosides. Moukha-chafiq O; Taha ML; Mouna A Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1107-10. PubMed ID: 18058546 [TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol. Lin TS; Schinazi R; Griffith BP; August EM; Eriksson BF; Zheng DK; Huang LA; Prusoff WH Antimicrob Agents Chemother; 1989 Dec; 33(12):2149-51. PubMed ID: 2619282 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1). Martin JA; Bushnell DJ; Duncan IB; Dunsdon SJ; Hall MJ; Machin PJ; Merrett JH; Parkes KE; Roberts NA; Thomas GJ J Med Chem; 1990 Aug; 33(8):2137-45. PubMed ID: 2165161 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs. De Clercq E; Walker RT Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893 [TBL] [Abstract][Full Text] [Related]
32. Bicyclic nucleoside inhibitors of varicella-zoster virus: 5'-chloro and 3'-chloro derivatives. Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):931-3. PubMed ID: 14565314 [TBL] [Abstract][Full Text] [Related]
33. [Reverse transcriptase inhibitors and the therapy of HIV infection]. Kraevskiĭ AA; Galegov GA Vestn Ross Akad Med Nauk; 1992; (11-12):3-6. PubMed ID: 1284219 [TBL] [Abstract][Full Text] [Related]
34. Side-chain derivatives of biologically active nucleosides. 1. Side-chain analogs of 3'-azido-3'-deoxythymidine (AZT). Hiebl J; Zbiral E; Balzarini J; De Clercq E J Med Chem; 1992 Aug; 35(16):3016-23. PubMed ID: 1323681 [TBL] [Abstract][Full Text] [Related]
35. 5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity. El Safadi Y; Paillart JC; Laumond G; Aubertin AM; Burger A; Marquet R; Vivet-Boudou V J Med Chem; 2010 Feb; 53(4):1534-45. PubMed ID: 20112915 [TBL] [Abstract][Full Text] [Related]
37. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1. Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides. Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142 [TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Chu CK; Schinazi RF; Ahn MK; Ullas GV; Gu ZP J Med Chem; 1989 Mar; 32(3):612-7. PubMed ID: 2918508 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents. Liu LJ; Hong JH Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]